Trane Technologies
TT NYSE Building Products Financials FY2016βFY2025
Trane Technologies' revenue rose 7.5% to $21.3 billion in fiscal 2025. Its operating margin was 18.6%, up from 17.6% a year earlier. Free cash flow was $2.8 billion, up 1.3%. It paid out $2.3 billion in dividends and buybacks, 82% of free cash flow. The diluted share count fell 1.5%.
What Trane Technologies does
No business description yet.
- Legal name
- TRANE TECHNOLOGIES PLC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-005731
0001466258
Revenue and margins
Trane Technologies had $21.3B of revenue in fiscal 2025, up 7.5% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 9.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $2.8B in fiscal 2025, 13.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Trane Technologies returned $2.3B to shareholders in fiscal 2025, 82% of free cash flow. The diluted share count fell 1.5%.
Value Trane Technologies yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$2.9B and divides by 224.9M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 33.7x Β· peers 26.0x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Trane Technologies can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.2B | $1.2B | $1.1B | $1.6B | $1.8B |
| Debt incl. finance leases | $4.8B | $4.8B | $4.8B | $4.8B | $4.6B |
| Net debt / EBITDA | 1.2x | 1.3x | 1.1x | 0.8x | 0.7x |
| Debt / equity | 0.8x | 0.8x | 0.7x | 0.6x | 0.5x |
| Interest coverage | 8.7x | 10.8x | 12.3x | 14.7x | 17.5x |
| Current ratio | 1.4x | 1.1x | 1.1x | 1.2x | 1.3x |
| Quick ratio | 1.0x | 0.8x | 0.8x | 0.9x | 0.9x |
| Total assets | $18.1B | $18.1B | $19.4B | $20.1B | $21.4B |
| Total liabilities | $11.8B | $12.0B | $12.4B | $12.7B | $12.8B |
| Shareholders' equity | $6.3B | $6.1B | $7.0B | $7.5B | $8.6B |
| Net debt (β = net cash) | $2.7B | $3.6B | $3.7B | $3.2B | $2.9B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.2M
1 insider
Sold, 12 months
$74.5M
5 insiders
Of sales under plans
100%
$74.5M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 6, 2026 | David S RegneryChair and CEO, Director | Sold plan | 48,091 | $480.00 | $23.1M | Form 4 |
| Aug 5, 2026 | David S RegneryChair and CEO, Director | Sold plan | 43,778 | $475.00 | $20.8M | Form 4 |
| Aug 4, 2026 | Melissa N. SchaefferDirector | Sold | 145 | $472.27 | $0.1M | Form 4 |
| Apr 30, 2026 | Donald E. SimmonsGroup President, Americas | Sold plan | 4,593 | $500.00 | $2.3M | Form 4 |
| Apr 8, 2026 | Christopher J KuehnExecutive Vice President & CFO | Sold plan | 8,619 | $450.00 | $3.9M | Form 4 |
| Mar 6, 2026 | David S RegneryChair and CEO, Director | Sold plan | 36,045 | $422.69 | $15.2M | Form 4 |
| Mar 6, 2026 | Donald E. SimmonsGroup President, Americas | Sold plan | 3,762 | $422.70 | $1.6M | Form 4 |
| Mar 6, 2026 | Elizabeth A. ElwellVP & Chief Accounting Officer | Sold plan | 635 | $422.71 | $0.3M | Form 4 |
| Mar 5, 2026 | John A HayesDirector | Bought | 400 | $430.44 | $0.2M | Form 4 |
| Feb 12, 2026 | Donald E. SimmonsGroup President, Americas | Sold plan | 7,663 | $475.00 | $3.6M | Form 4 |
| Feb 10, 2026 | Christopher J KuehnExecutive Vice President & CFO | Sold plan | 2,389 | $462.70 | $1.1M | Form 4 |
| Feb 10, 2026 | David S RegneryChair and CEO, Director | Sold plan | 5,588 | $462.60 | $2.6M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 8 / 8 | 8 / 8 | 8 / 8 |
| Accruals ratio | β2.0% | β2.9% | β1.3% |
| Altman Z'' | 3.41 | 3.79 | 4.02 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Trane Technologies TT | $99.0B | 7.5% | 18.6% | 13.2% | 29.0% | 33.7x | 8 | |
| Carrier Global CARR | $47.4B | β3.3% | 10.0% | 9.8% | 8.0% | 36.8x | 5 | Compare β |
| Johnson Controls JCI | $88.4B | 2.8% | β | 9.0% | 8.2% | 26.0x | 6 | Compare β |
| Owens Corning OC | $9.2B | 2.6% | 3.6% | 9.5% | 1.9% | β | 4 | Compare β |
| Masco MAS | $15.5B | β3.4% | 16.5% | 11.5% | 40.4% | 18.9x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $13.5B | $14.2B | $12.3B | $13.1B | $12.5B | $14.1B | $16.0B | $17.7B | $19.8B | $21.3B |
| Gross profit | $4.2B | $4.4B | $3.8B | $4.0B | $3.8B | β | β | β | β | β |
| Research and development | $208M | $211M | $167M | $174M | $165M | $194M | $211M | $252M | $310M | $348M |
| Operating income | $1.6B | $1.7B | $1.5B | $1.7B | $1.5B | $2.0B | $2.4B | $2.9B | $3.5B | $4.0B |
| Interest expense | $222M | $216M | $221M | $243M | $249M | $234M | $224M | $235M | $238M | $227M |
| Pretax income | $1.7B | $1.4B | $1.3B | $1.4B | $1.3B | $1.8B | $2.2B | $2.6B | $3.2B | $3.7B |
| Income tax | $282M | $80.2M | $235M | $239M | $297M | $334M | $376M | $498M | $628M | $706M |
| Net income | $1.5B | $1.3B | $1.3B | $1.4B | $855M | $1.4B | $1.8B | $2.0B | $2.6B | $2.9B |
| Diluted EPS | $5.65 | $5.05 | $5.35 | $5.77 | $3.52 | $5.87 | $7.48 | $8.77 | $11.24 | $12.98 |
| Diluted shares | 0.26B | 0.26B | 0.25B | 0.24B | 0.24B | 0.24B | 0.23B | 0.23B | 0.23B | 0.22B |
| Cash flow | ||||||||||
| Cash from operations | $1.5B | $1.5B | $1.4B | $1.9B | $1.4B | $1.6B | $1.5B | $2.4B | $3.1B | $3.2B |
| Capital expenditure | $183M | $221M | $285M | $205M | $146M | $223M | $292M | $301M | $371M | $383M |
| Free cash flow | $1.3B | $1.3B | $1.1B | $1.7B | $1.3B | $1.4B | $1.2B | $2.1B | $2.8B | $2.8B |
| Depreciation and amortization | $352M | $353M | $362M | $397M | $294M | $299M | $324M | $348M | $379M | $376M |
| Stock-based compensation | $69.6M | $70.8M | $78.8M | $66.4M | $69.5M | $66.5M | $56.3M | $64.3M | $82.9M | $86.6M |
| Acquisitions | $9.2M | $158M | $286M | $83.4M | $183M | $269M | $235M | $863M | $180M | $276M |
| Share buybacks | $250M | $1.0B | $900M | $750M | $250M | $1.1B | $1.2B | $669M | $1.3B | $1.5B |
| Dividends paid | $349M | $430M | $480M | $510M | $507M | $561M | $620M | $684M | $758M | $837M |
| Dividends and buybacks | $599M | $1.4B | $1.4B | $1.3B | $757M | $1.7B | $1.8B | $1.4B | $2.0B | $2.3B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $1.7B | $1.5B | $878M | $1.3B | $3.3B | $2.2B | $1.2B | $1.1B | $1.6B | $1.8B |
| Total debt | $4.2B | $4.1B | $4.1B | $5.6B | $5.3B | $4.8B | $4.8B | $4.8B | $4.8B | $4.6B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $5.6B | $6.1B | $5.7B | $9.3B | $6.9B | $6.5B | $6.4B | $6.9B | $7.3B | $7.9B |
| Current liabilities | $3.6B | $4.8B | $4.3B | $5.2B | $4.3B | $4.8B | $5.7B | $6.1B | $6.1B | $6.3B |
| Inventory | $1.4B | $1.6B | $1.7B | $1.3B | $1.2B | $1.5B | $2.0B | $2.2B | $2.0B | $2.1B |
| Property and equipment, net | $1.5B | $1.6B | $1.7B | $1.4B | $1.3B | $1.4B | $1.5B | $1.8B | $2.0B | $2.3B |
| Total assets | $17.4B | $18.2B | $17.9B | $20.5B | $18.2B | $18.1B | $18.1B | $19.4B | $20.1B | $21.4B |
| Total liabilities | $10.7B | $11.0B | $10.9B | $13.2B | $11.7B | $11.8B | $12.0B | $12.4B | $12.7B | $12.8B |
| Shareholders' equity | $6.6B | $7.1B | $7.0B | $7.3B | $6.4B | $6.3B | $6.1B | $7.0B | $7.5B | $8.6B |
| Margins | ||||||||||
| Gross margin | 31.1% | 30.9% | 30.5% | 30.5% | 30.5% | β | β | β | β | β |
| Operating margin | 11.9% | 11.7% | 12.3% | 12.8% | 12.3% | 14.3% | 15.1% | 16.4% | 17.6% | 18.6% |
| EBITDA margin | 14.5% | 14.2% | 15.2% | 15.8% | 14.7% | 16.4% | 17.2% | 18.3% | 19.6% | 20.4% |
| Net margin | 10.9% | 9.2% | 10.8% | 10.8% | 6.9% | 10.1% | 11.0% | 11.5% | 12.9% | 13.7% |
| FCF margin | 9.9% | 9.2% | 9.1% | 13.1% | 10.4% | 9.7% | 7.6% | 11.8% | 14.0% | 13.2% |
| Returns | ||||||||||
| Return on capital | 14.5% | 16.6% | 12.3% | 12.7% | 11.8% | 19.0% | 21.4% | 22.8% | 26.4% | 29.0% |
| Return on capital employed | 11.9% | 12.3% | 11.2% | 11.6% | 10.6% | 14.9% | 18.8% | 22.5% | 25.5% | 27.2% |
| Return on equity | 23.7% | 18.9% | 18.9% | 19.8% | 12.5% | 22.5% | 28.5% | 30.9% | 35.5% | 36.4% |
| Return on assets | 8.7% | 7.3% | 7.4% | 7.4% | 4.4% | 7.9% | 9.7% | 10.8% | 13.0% | 14.0% |
| Growth | ||||||||||
| Revenue growth | 1.6% | 5.1% | β13.1% | 5.9% | β4.8% | 13.5% | 13.1% | 10.5% | 12.2% | 7.5% |
| Net income growth | 122.1% | β11.8% | 2.7% | 5.5% | β39.4% | 66.5% | 23.4% | 15.2% | 26.9% | 13.7% |
| EPS growth | 127.8% | β10.6% | 5.9% | 7.9% | β39.0% | 66.8% | 27.4% | 17.3% | 28.2% | 15.5% |
| FCF growth | 109.6% | β2.8% | β13.8% | 52.6% | β24.8% | 5.9% | β11.2% | 72.3% | 32.9% | 1.3% |
| Share count change | β2.3% | β1.4% | β3.1% | β2.3% | β0.5% | β0.3% | β3.1% | β1.8% | β1.0% | β1.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.3x | 1.3x | 1.7x | 2.1x | 1.1x | 1.2x | 1.3x | 1.1x | 0.8x | 0.7x |
| Debt / equity | 0.6x | 0.6x | 0.6x | 0.8x | 0.8x | 0.8x | 0.8x | 0.7x | 0.6x | 0.5x |
| Interest coverage | 7.2x | 7.7x | 6.8x | 6.9x | 6.2x | 8.7x | 10.8x | 12.3x | 14.7x | 17.5x |
| Current ratio | 1.6x | 1.3x | 1.3x | 1.8x | 1.6x | 1.4x | 1.1x | 1.1x | 1.2x | 1.3x |
| Quick ratio | 1.2x | 1.0x | 0.9x | 1.5x | 1.3x | 1.0x | 0.8x | 0.8x | 0.9x | 0.9x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.4% | 1.6% | 2.3% | 1.6% | 1.2% | 1.6% | 1.8% | 1.7% | 1.9% | 1.8% |
| Stock comp / revenue | 0.5% | 0.5% | 0.6% | 0.5% | 0.6% | 0.5% | 0.4% | 0.4% | 0.4% | 0.4% |
| Payouts / FCF | 44.7% | 111.1% | 122.9% | 73.5% | 58.8% | 121.7% | 150.2% | 64.8% | 73.5% | 82.5% |
| Quality scores | ||||||||||
| Piotroski F-score | 9.0 | 6.0 | 6.0 | 8.0 | 6.0 | 7.0 | 5.0 | 8.0 | 8.0 | 8.0 |
| Altman Z'' | 3.5 | 3.4 | 3.5 | 4.0 | 3.6 | 3.4 | 3.2 | 3.4 | 3.8 | 4.0 |
| Accruals ratio | β0.3% | β1.2% | β0.4% | β2.7% | β3.0% | β0.9% | 1.4% | β2.0% | β2.9% | β1.3% |
Source: SEC EDGAR XBRL filings (CIK 0001466258). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.